New MS Drug Approved — Ofatumumab is first self-administered, targeted B-cell treatment for relapsing MS
Discussion in 'Other health news and research' started by Jaybee00, Aug 21, 2020.
Discussion in 'Other health news and research' started by Jaybee00, Aug 21, 2020.